Global assembling of Academicians, Researchers, Scholars & Industry to disseminate and exchange information at 100+ Allied Academics Conferences

Theme
Diabetes Management address improvements in Current Therapeutics
- Clinical Diabetes 2017

About Conference

The exciting and innovative program brought together national and international experts to promote the exchange of the latest clinical practices and cutting edge research in diabetes. State-of-the-Art lectures, free communication sessions and clinical and scientific educational symposia, were appreciated by the 2016 attendees. With this enthusiastic support of our Organizing Committee and Editorial Board Member, we are overwhelmed to announce “26th International Conference on Clinical Diabetes (Clinical Diabetes 2017) as a continuum of our previous successful conference. Clinical Diabetes 2017 will be held in Rome, Italy during December 14-15, 2017. The conference will focus on Diabetes Management address improvements in Current Therapeutics

The program organizing committee consists of members from all three societies and endeavors to present you with the latest and most exciting data from these respective fields with a range of international and national leading speakers. The benefits of this large scale collaborative meeting include: broader content areas, efficiency in meeting attendance and costs for delegates and trade partners, a more diverse variety of sessions, and increased attendees. Our scientific program includes invited plenary presentations, symposia and seminars, meet-the-professor sessions, basic and clinical abstract presentations, young investigator awards, and interactive poster sessions. Our speakers are drawn from a truly international profile, with themes in contemporary Diabetes and its related disorders and Therapies.

Allied Academic Publication is an amalgamation of several esteemed academic and scientific associations known for promoting scientific temperament. Established in the year 1997, Andrew John Publishing Group is a specialized Medical publisher that operates in collaboration with the association and societies.  This publishing house has been built on the base of esteemed academic and research institutions including The College of Audiologists and Speech Language Pathologists of Ontario(CASLPO), The Association for Public Safety Communications Officials of Canada (APCO), The Canadian Vascular Access Association (CVAA), The Canadian Society of Internal Medicine (CSIM), The Canadian Hard of Hearing Association (CHHA), Sonography Canada, Canadian Association of Pathologists (CAP-ACP) and The Canadian Association of Neurophysiologic Monitoring (CANM).

Why to Attend?

The meeting will provide many opportunities to network and discuss science and medicine, ensure equity of opportunity, find new funding and research opportunities, and build collaborations and contacts with international colleagues. We are sure that you will find this to be a truly exciting meeting presenting both the breadth and depth of clinical and basic research.  Trade partners will have exposure to more areas of specialties in Diabetes and Endocrinology. World Class Speakers and Fresh New Talent from across the Globe in Health Industry gather in this world congress.

Target Audience

Diabetologists

Endocrinologists

Doctors

Researchers

Physicians

Business Professionals

Academic Professionals

Students

Scientists

Medical and Pharma Companies

Medical Colleges and Hospitals

Diabetes Societies and Associations

Sessions/Tracks

Track 1: Clinical Diabetes & Diagnostic Approaches

Diabetes mellitus is a gathering of metabolic ailments described by hyperglycaemia coming about because of imperfections in insulin secretion, insulin activity, or both. The perpetual hyperglycaemia of diabetes is related with long-term damage, dysfunction, and failure of various organs, especially the eyes, kidneys, nerves, heart, and blood vessels.

Diabetic kidney infection is perceived as the main source of overaDiabetes Mellitusbundance mortality in the populace with type 1 diabetes. The overarching hypothesis is that overabundance calories are handled by means of the mitochondria bringing about gathering of superoxide radicals by means of the electron exchange chain. Novel Paradigms in Diabetic Complications, Diabetes, Pre-diabetes speaks to a rise of plasma glucose over the typical range yet beneath that of clinical diabetes. Prediabetes and Metabolic Syndrome, To better review both the pathogenesis and potential helpful operators, suitable creature models of type 2 diabetes (T2D) mellitus are required for Clinical trials on creature models, sodium glucose co-transport inhibitors go about as a novel methodology for the treatment of diabetes mellitus

Type 2 diabetes is by a wide margin the most well-known kind of diabetes in grown-ups (>90 percent) and is portrayed by hyperglycaemia and variable degrees of insulin lack and resistance in Clinical introduction and conclusion of diabetes mellitus in grown-ups.

Related Conference Diabetes | Diabetes Conferences | Diabetes Congress | Diabetes Meetings | Diabetologist | Endocrinology Conferences |

20th World Summit on Diabetes, Nutrition, Metabolism & Medicare July 24-26,2017 Vancouver, Canada; 23rd International Conference on Herbal and Alternative Remedies for Diabetes and Endocrine Disorders November 2-4, 2017 Bangkok, Thailand; 18th European Diabetes Congress July 17-18, 2017 Lisbon, Portugal; 10th Diabetologists Conference July 24-26,2017 Vancouver, Canada; 19th Asia Pacific Diabetes Conference July 20-22, 2017 Melbourne, Australia; 16th Global Diabetes Conference & Medicare Expo March 22-23, 2017 Rome, Italy; 8th International Conference on Adrenal & Thyroid Disorders, Treatment June 12-13, 2017 Taiwan, Taipei; 13th World Congress on Diabetes  October 05-06, 2017 London, UK; 12th International Conference on Endocrinology and Diabetes Summit November 06-07, 2017 Singapore.

Related Diabetes Societies and Associations

Egyptian Society of Diabetic foot;  Society of Endocrinology, Metabolism and Diabetes of South Africa; The Asian Association for the study of Diabetes; Japan Diabetes Society; Qatar Diabetes Association; Malaysian Diabetes Educators Society; The Japan Diabetes Society; Asia Pacific Association on Diabetic Limb Problems; Australian Diabetes Society; Australian Diabetes Educators Association; New Zealand Dietetic Association


Track 2: Clinical Diabetes Management

People with type 1 or type 2 diabetes are diagnosed with more of some types of cancer -- and are more likely to die from cancer -- than people without diabetes, a new Australian study shows.The brain is a hugely important organ which helps to be aware of, understand and interact with our surroundings and others.As with many of our organs, the brain is susceptible to damage as a result of diabetes & brain

Diabetes foot care & management: Foot ulcers and amputations are a major cause of morbidity, disability, as well as emotional and physical costs for people with diabetes. Early recognition and management of independent risk factors for ulcers and amputations can prevent or delay the onset of adverse outcomes.

Implantable Cardioverter Defibrillator An ICD is a battery-powered device placed under the skin that keeps track of your heart rate. Thin wires connect the ICD to your heart. If an abnormal heart rhythm is detected the device will deliver an electric shock to restore a normal heartbeat if your heart is beating chaotically and much too fast. It is important to understand that the decision to have angioplasty or coronary artery bypass graft (CABG) surgery to treat coronary artery disease (CAD) depends on many different things. A healthful eating pattern, regular physical activity, and often pharmacotherapy are key components of diabetes management. It is best to get vitamins and minerals from the foods you eat. In fact, research has not been able to prove that dietary or herbal supplements (including omega-3 supplements, cinnamon, and other herbs) help to manage diabetes.

Related Conference Diabetes | Diabetes Conferences | Diabetes Congress | Diabetes Meetings | Diabetologist | Endocrinology Conferences |

20th World Summit on Diabetes, Nutrition, Metabolism & Medicare July 24-26,2017 Vancouver, Canada; 23rd International Conference on Herbal and Alternative Remedies for Diabetes and Endocrine Disorders November 2-4, 2017 Bangkok, Thailand; 18th European Diabetes Congress July 17-18, 2017 Lisbon, Portugal; 10th Diabetologists Conference July 24-26,2017 Vancouver, Canada; 19th Asia Pacific Diabetes Conference July 20-22, 2017 Melbourne, Australia; 16th Global Diabetes Conference & Medicare Expo March 22-23, 2017 Rome, Italy; 8th International Conference on Adrenal & Thyroid Disorders, Treatment June 12-13, 2017 Taiwan, Taipei; 13th World Congress on Diabetes  October 05-06, 2017 London, UK; 12th International Conference on Endocrinology and Diabetes Summit November 06-07, 2017 Singapore.

Related Diabetes Societies and Associations

European Society of Endocrine Surgeons; Primary Care Diabetes Society; European Society of Endocrinology; European Society for Gynaecological Endoscopy; International Society for Paediatric and Adolescent Diabetes; Central European Diabetes Association-FID; Diabetes Society; European Society for Paediatric Endocrinology; British Diabetic Association (BDA); The European Association for the study of Diabetes; Society for Biomedical Diabetes Research; French Language Association for the Diabetes Study ALFEDIAM 


Track3: Diabetes Case Studies

Diabetes case reports are in-depth inquiries of an individual, crowd, occasion or public. The data are assembled from a diversity of places by various methods. The case study technique encompasses spotting what happens to, or reconstructing ‘the case history’ of a single participant or group of individuals, i.e. the idiographic approach. Case studies permits an investigator to investigate a topic in far more detailed and minute way. The case study is not itself a research method, but investigators choose methods of data collection and analysis that will generate material suitable for case studies. Most of this evidence is likely to be qualitative but the psychologist might collect numerical data as well and present in various diabetes conference and scientific sessions.

Related Conference Diabetes | Diabetes Conferences | Diabetes Congress | Diabetes Meetings | Diabetologist | Endocrinology Conferences |

20th World Summit on Diabetes, Nutrition, Metabolism & Medicare July 24-26,2017 Vancouver, Canada; 23rd International Conference on Herbal and Alternative Remedies for Diabetes and Endocrine Disorders November 2-4, 2017 Bangkok, Thailand; 18th European Diabetes Congress July 17-18, 2017 Lisbon, Portugal; 10th Diabetologists Conference July 24-26,2017 Vancouver, Canada; 19th Asia Pacific Diabetes Conference July 20-22, 2017 Melbourne, Australia; 16th Global Diabetes Conference & Medicare Expo March 22-23, 2017 Rome, Italy; 8th International Conference on Adrenal & Thyroid Disorders, Treatment June 12-13, 2017 Taiwan, Taipei; 13th World Congress on Diabetes  October 05-06, 2017 London, UK; 12th International Conference on Endocrinology and Diabetes Summit November 06-07, 2017 Singapore.

Related Diabetes Societies and Associations

The Scandinavian society for the study of diabetes; American Diabetes Association; European Association for the Study of Diabetes -DNSG-EASD; World Glaucoma Association; Austrian Society for Urology (OGU); Cyprus Endocrine Society; Endocrine Pathology Society; Diabetes Technology Society; International Society of Endocrinology; International Association of Endocrine Surgeons; Canadian Diabetes Association; ALAD Latin American Diabetes Association 


Track4: Symptoms & prevention of diabetes


Diabetes is a severe illness that cannot be cured of its own. Doctor aids to create a diabetes management plan that is right for the patient. Cure for diabetes demands to keep close watch over the blood sugar level with a combination of medications, work out, and diet. Since the spectacular finding in Toronto in 1922 that type 1 diabetes arises from a deficit of insulin. Research on Insulin is extensively discussed in National Diabetes Conference and Diabetes associations. The supervision of diabetes has been decisively grounded in scientific advances that endure to outline our understanding of the pathophysiology of diabetes  and direct our choices in choosing optimal therapies for type 1 and type 2 diabetes. Now, a days we get in market glucose meters which is a modern technology which has the capability to help people living with type 1 or type 2 diabetes and treated with insulin to accomplish the dream of ideal control of blood sugar.

Related Conference Diabetes | Diabetes Conferences | Diabetes Congress | Diabetes Meetings | Diabetologist | Endocrinology Conferences |

20th World Summit on Diabetes, Nutrition, Metabolism & Medicare July 24-26,2017 Vancouver, Canada; 23rd International Conference on Herbal and Alternative Remedies for Diabetes and Endocrine Disorders November 2-4, 2017 Bangkok, Thailand; 18th European Diabetes Congress July 17-18, 2017 Lisbon, Portugal; 10th Diabetologists Conference July 24-26,2017 Vancouver, Canada; 19th Asia Pacific Diabetes Conference July 20-22, 2017 Melbourne, Australia; 16th Global Diabetes Conference & Medicare Expo March 22-23, 2017 Rome, Italy; 8th International Conference on Adrenal & Thyroid Disorders, Treatment June 12-13, 2017 Taiwan, Taipei; 13th World Congress on Diabetes  October 05-06, 2017 London, UK; 12th International Conference on Endocrinology and Diabetes Summit November 06-07, 2017 Singapore.

Related Diabetes Societies and Associations

Egyptian Society of Diabetic foot;  Society of Endocrinology, Metabolism and Diabetes of South Africa; The Asian Association for the study of Diabetes; Japan Diabetes Society; Qatar Diabetes Association; Malaysian Diabetes Educators Society; The Japan Diabetes Society; Asia Pacific Association on Diabetic Limb Problems; Australian Diabetes Society; Australian Diabetes Educators Association; New Zealand Dietetic Association


Track 5: Endocrinology: Disorder and Treatment

Clinical Endocrinology and metabolism is a field of medicine; more precisely a sub-specialty of internal medicine, which mainly deals with the investigation and management of sicknesses related to hormones. The human endocrine system involves number of glands. These glands harvest and release hormones which monitors many important function of our body. When the hormones exits the glands they arrive the bloodstream and are moved to organs and tissues in every part of the body. Endocrinology also concentrates on the endocrine glands and tissues that secrete hormones. The human endocrine system comprises of several glands. These glands harvest and secrete hormones which regulates the body's metabolism, growth, sexual development and function. Hormonal imbalance in our body henceforth leads to diabetes.  


Related Conference Diabetes | Diabetes Conferences | Diabetes Congress | Diabetes Meetings | Diabetologist | Endocrinology Conferences |

20th World Summit on Diabetes, Nutrition, Metabolism & Medicare July 24-26,2017 Vancouver, Canada; 23rd International Conference on Herbal and Alternative Remedies for Diabetes and Endocrine Disorders November 2-4, 2017 Bangkok, Thailand; 18th European Diabetes Congress July 17-18, 2017 Lisbon, Portugal; 10th Diabetologists Conference July 24-26,2017 Vancouver, Canada; 19th Asia Pacific Diabetes Conference July 20-22, 2017 Melbourne, Australia; 16th Global Diabetes Conference & Medicare Expo March 22-23, 2017 Rome, Italy; 8th International Conference on Adrenal & Thyroid Disorders, Treatment June 12-13, 2017 Taiwan, Taipei; 13th World Congress on Diabetes  October 05-06, 2017 London, UK; 12th International Conference on Endocrinology and Diabetes Summit November 06-07, 2017 Singapore.

Related Diabetes Societies and Associations

European Society of Endocrine Surgeons; Primary Care Diabetes Society; European Society of Endocrinology; European Society for Gynaecological Endoscopy; International Society for Paediatric and Adolescent Diabetes; Central European Diabetes Association-FID; Diabetes Society; European Society for Paediatric Endocrinology; British Diabetic Association (BDA); The European Association for the study of Diabetes; Society for Biomedical Diabetes Research; French Language Association for the Diabetes Study ALFEDIAM


Track 6 : Diabetes Chronic Complications

The term diabetes mellitus describes several diseases of abnormal carbohydrate metabolism that are characterized by hyperglycemia. It is associated with a relative or absolute impairment in insulin secretion, along with varying degrees of peripheral resistance to the action of insulin. They are derived after doing many clinical trials on animal models. Every few years, the diabetes community revaluates the current recommendations for the classification, diagnosis, and screening of diabetes, reflecting new information from research and clinical practice which in turns help in understanding current prevention and treatment options and cost effectiveness in treatment and prevention of Diabetes. People with type1 and type2 diabetes have an increased risk of developing a number of serious health problems. Consistently high blood glucose levels can lead to serious diseases affecting the Macro vascular and micro vascular complications. In addition, people with diabetes also have a higher risk of developing infections. In almost all high-income countries, diabetes is a leading cause of cardiovascular disease, blindness, kidney failure, and lower limb amputation. Maintaining blood glucose levels, blood pressure, and cholesterol at or close to normal can help delay or prevent diabetes complications. Hypoglycemia and Hyperglycemia are the other two factors are the two major complications of diabetes where hyperglycemia is an acute complication sharing many symptoms and hypoglycemia is an acute complication of several diabetes treatments. Glycosylated hemoglobin is a form of hemoglobin that is measured primarily to identify the average plasma glucose concentration over prolonged periods of time.

Related Conference Diabetes | Diabetes Conferences | Diabetes Congress | Diabetes Meetings | Diabetologist | Endocrinology Conferences |

20th World Summit on Diabetes, Nutrition, Metabolism & Medicare July 24-26,2017 Vancouver, Canada; 23rd International Conference on Herbal and Alternative Remedies for Diabetes and Endocrine Disorders November 2-4, 2017 Bangkok, Thailand; 18th European Diabetes Congress July 17-18, 2017 Lisbon, Portugal; 10th Diabetologists Conference July 24-26,2017 Vancouver, Canada; 19th Asia Pacific Diabetes Conference July 20-22, 2017 Melbourne, Australia; 16th Global Diabetes Conference & Medicare Expo March 22-23, 2017 Rome, Italy; 8th International Conference on Adrenal & Thyroid Disorders, Treatment June 12-13, 2017 Taiwan, Taipei; 13th World Congress on Diabetes  October 05-06, 2017 London, UK; 12th International Conference on Endocrinology and Diabetes Summit November 06-07, 2017 Singapore.

Related Diabetes Societies and Associations

The Scandinavian society for the study of diabetes; American Diabetes Association; European Association for the Study of Diabetes -DNSG-EASD; World Glaucoma Association; Austrian Society for Urology (OGU); Cyprus Endocrine Society; Endocrine Pathology Society; Diabetes Technology Society; International Society of Endocrinology; International Association of Endocrine Surgeons; Canadian Diabetes Association; ALAD Latin American Diabetes Association 


Track 7: Diabetes and Associated Diseases

Diabetes intensifies the danger of long-term complications. Diabetes increases the risk of cardiovascular diseases such as diabetic cardiomyopathy. The chief complications of diabetes due to injury in small blood vessels comprise damage to the eyes, kidneys, and nerves. Damage to the eyes is known as diabetic retinopathy which is triggered by damage to the blood vessels in the retina of the eye leading to diabetic eye complications. Damage to the kidneys, known as diabetic nephropathy, can pave the way to tissue damaging, urine protein damage, and eventually diabetic nephropathy disease. Diabetes is one of the main cause of kidney failure. At least two third of the people with diabetes may have signs of onset of kidney problems at early stage. Damage to the nerves of the body, known as diabetic neuropathy, is the most common complication of diabetes.

Related Conference Diabetes | Diabetes Conferences | Diabetes Congress | Diabetes Meetings | Diabetologist | Endocrinology Conferences |

20th World Summit on Diabetes, Nutrition, Metabolism & Medicare July 24-26,2017 Vancouver, Canada; 23rd International Conference on Herbal and Alternative Remedies for Diabetes and Endocrine Disorders November 2-4, 2017 Bangkok, Thailand; 18th European Diabetes Congress July 17-18, 2017 Lisbon, Portugal; 10th Diabetologists Conference July 24-26,2017 Vancouver, Canada; 19th Asia Pacific Diabetes Conference July 20-22, 2017 Melbourne, Australia; 16th Global Diabetes Conference & Medicare Expo March 22-23, 2017 Rome, Italy; 8th International Conference on Adrenal & Thyroid Disorders, Treatment June 12-13, 2017 Taiwan, Taipei; 13th World Congress on Diabetes  October 05-06, 2017 London, UK; 12th International Conference on Endocrinology and Diabetes Summit November 06-07, 2017 Singapore.

Related Diabetes Societies and Associations

Egyptian Society of Diabetic foot;  Society of Endocrinology, Metabolism and Diabetes of South Africa; The Asian Association for the study of Diabetes; Japan Diabetes Society; Qatar Diabetes Association; Malaysian Diabetes Educators Society; The Japan Diabetes Society; Asia Pacific Association on Diabetic Limb Problems; Australian Diabetes Society; Australian Diabetes Educators Association; New Zealand Dietetic Association


Track 8: Insulin Medication

Insulin therapy is recommended for patients with type 2 diabetes mellitus and an initial A1C level greater than 9 percent, or if diabetes is uncontrolled despite optimal oral glycemic therapy. Insulin therapy may be initiated as augmentation, starting at 0.3 units per kg, or as replacement, starting at 0.6 to 1.0 units per kg. Glucose control, adverse effects, cost, adherence, and quality of life need to be considered when choosing therapy. Metformin should be continued if possible because it is proven to reduce all-cause mortality and cardiovascular events in overweight patients with diabetes. Titration of insulin over time is critical to improving glycemic control and preventing diabetes-related complications.

Related Conference Diabetes | Diabetes Conferences | Diabetes Congress | Diabetes Meetings | Diabetologist | Endocrinology Conferences |

20th World Summit on Diabetes, Nutrition, Metabolism & Medicare July 24-26,2017 Vancouver, Canada; 23rd International Conference on Herbal and Alternative Remedies for Diabetes and Endocrine Disorders November 2-4, 2017 Bangkok, Thailand; 18th European Diabetes Congress July 17-18, 2017 Lisbon, Portugal; 10th Diabetologists Conference July 24-26,2017 Vancouver, Canada; 19th Asia Pacific Diabetes Conference July 20-22, 2017 Melbourne, Australia; 16th Global Diabetes Conference & Medicare Expo March 22-23, 2017 Rome, Italy; 8th International Conference on Adrenal & Thyroid Disorders, Treatment June 12-13, 2017 Taiwan, Taipei; 13th World Congress on Diabetes  October 05-06, 2017 London, UK; 12th International Conference on Endocrinology and Diabetes Summit November 06-07, 2017 Singapore. 

Related Diabetes Societies and Associations

European Society of Endocrine Surgeons; Primary Care Diabetes Society; European Society of Endocrinology; European Society for Gynaecological Endoscopy; International Society for Paediatric and Adolescent Diabetes; Central European Diabetes Association-FID; Diabetes Society; European Society for Paediatric Endocrinology; British Diabetic Association (BDA); The European Association for the study of Diabetes; Society for Biomedical Diabetes Research; French Language Association for the Diabetes Study ALFEDIAM


Track 9 : Treatment for Clinical Diabetes

Blood glucose (blood sugar) monitoring is the main tool you have to check your diabetes control. This check tells you your blood glucose level at any one time. The artificial pancreas bridges the gap between two pieces of diabetes technology that already exist: the insulin pump and the continuous glucose monitor (CGM). Relatively, a large percentage of world population is affected by diabetes mellitus, out of which approximately 5-10% with type 1 diabetes while the remaining 90% with type 2. Insulin administration is essential for type 1 patients while it is required at later stage by the patients of type 2. Current insulin delivery systems are available as transdermal injections which may be considered as invasive. Several non-invasive approaches for insulin delivery are being pursued by pharmaceutical companies to reduce the pain, and hypoglycemic incidences associated with injections in order to improve patient compliance.

Related Conference Diabetes | Diabetes Conferences | Diabetes Congress | Diabetes Meetings | Diabetologist | Endocrinology Conferences |

20th World Summit on Diabetes, Nutrition, Metabolism & Medicare July 24-26,2017 Vancouver, Canada; 23rd International Conference on Herbal and Alternative Remedies for Diabetes and Endocrine Disorders November 2-4, 2017 Bangkok, Thailand; 18th European Diabetes Congress July 17-18, 2017 Lisbon, Portugal; 10th Diabetologists Conference July 24-26,2017 Vancouver, Canada; 19th Asia Pacific Diabetes Conference July 20-22, 2017 Melbourne, Australia; 16th Global Diabetes Conference & Medicare Expo March 22-23, 2017 Rome, Italy; 8th International Conference on Adrenal & Thyroid Disorders, Treatment June 12-13, 2017 Taiwan, Taipei; 13th World Congress on Diabetes  October 05-06, 2017 London, UK; 12th International Conference on Endocrinology and Diabetes Summit November 06-07, 2017 Singapore.

Related Diabetes Societies and Associations

The Scandinavian society for the study of diabetes; American Diabetes Association; European Association for the Study of Diabetes -DNSG-EASD; World Glaucoma Association; Austrian Society for Urology (OGU); Cyprus Endocrine Society; Endocrine Pathology Society; Diabetes Technology Society; International Society of Endocrinology; International Association of Endocrine Surgeons; Canadian Diabetes Association; ALAD Latin American Diabetes Association 


Track 10: Market analysis of Diabetic products

Diabetes care market encompasses of technologies, devices and therapeutics in relative to diabetes. There has been a substantial increase in the amount of diabetes cases internationally over the last few years. Currently, about millions of people are in misery because of obesity, which is a key reason for increase of diabetes in people. Key Players profiled in the report include GlaxoSmithKline, Novo Nordisk, Roche, Medtronic and etc. Novo Nordisk is a leading global provider of diabetes products. The company also has a headship spot in haemostasis management, growth hormone therapy and hormone replacement therapy. The company progresses, manufactures and markets its medical devices and technologies to hospitals, doctors, researchers, scientists and patients in approximately 160 countries. 

Related Conference Diabetes | Diabetes Conferences | Diabetes Congress | Diabetes Meetings | Diabetologist | Endocrinology Conferences |

20th World Summit on Diabetes, Nutrition, Metabolism & Medicare July 24-26,2017 Vancouver, Canada; 23rd International Conference on Herbal and Alternative Remedies for Diabetes and Endocrine Disorders November 2-4, 2017 Bangkok, Thailand; 18th European Diabetes Congress July 17-18, 2017 Lisbon, Portugal; 10th Diabetologists Conference July 24-26,2017 Vancouver, Canada; 19th Asia Pacific Diabetes Conference July 20-22, 2017 Melbourne, Australia; 16th Global Diabetes Conference & Medicare Expo March 22-23, 2017 Rome, Italy; 8th International Conference on Adrenal & Thyroid Disorders, Treatment June 12-13, 2017 Taiwan, Taipei; 13th World Congress on Diabetes  October 05-06, 2017 London, UK; 12th International Conference on Endocrinology and Diabetes Summit November 06-07, 2017 Singapore.

Related Diabetes Societies and Associations

Egyptian Society of Diabetic foot;  Society of Endocrinology, Metabolism and Diabetes of South Africa; The Asian Association for the study of Diabetes; Japan Diabetes Society; Qatar Diabetes Association; Malaysian Diabetes Educators Society; The Japan Diabetes Society; Asia Pacific Association on Diabetic Limb Problems; Australian Diabetes Society; Australian Diabetes Educators Association; New Zealand Dietetic Association


Track 11: Genetic Disorders for Diabetes

Diabetes constitutes a significant public pathological state. Though substantial progress has been created in shaping the genetic science of metabolic syndrome risk for specific subtypes of polygenic disease (e.g., type 2 Diabetes of the young), the bulk of genetic risk of polygenic disease (for Type 1 and type 2) stay unresolved. This review focuses on the present information of the genetic basis of diabetes and its complications, specifically diabetic nephrosis (DN), recent advances in genetic science of Diabetes, Diabetes in ethnic teams, genetic manner interactions and understanding the genetic science of diabetes. Ultimately, identification of genes that contribute to risk (or protection) of diabetes and its complications can permit identification of patients United Nations agency have diabetes and area unit in danger and targeted treatment/interventional methods. Diabetic amyotrophic could be a disabling sickness that's distinct from alternative types of diabetic neuropathy.

Related Conference Diabetes | Diabetes Conferences | Diabetes Congress | Diabetes Meetings | Diabetologist | Endocrinology Conferences |

20th World Summit on Diabetes, Nutrition, Metabolism & Medicare July 24-26,2017 Vancouver, Canada; 23rd International Conference on Herbal and Alternative Remedies for Diabetes and Endocrine Disorders November 2-4, 2017 Bangkok, Thailand; 18th European Diabetes Congress July 17-18, 2017 Lisbon, Portugal; 10th Diabetologists Conference July 24-26,2017 Vancouver, Canada; 19th Asia Pacific Diabetes Conference July 20-22, 2017 Melbourne, Australia; 16th Global Diabetes Conference & Medicare Expo March 22-23, 2017 Rome, Italy; 8th International Conference on Adrenal & Thyroid Disorders, Treatment June 12-13, 2017 Taiwan, Taipei; 13th World Congress on Diabetes  October 05-06, 2017 London, UK; 12th International Conference on Endocrinology and Diabetes Summit November 06-07, 2017 Singapore.

Related Diabetes Societies and Associations

European Society of Endocrine Surgeons; Primary Care Diabetes Society; European Society of Endocrinology; European Society for Gynaecological Endoscopy; International Society for Paediatric and Adolescent Diabetes; Central European Diabetes Association-FID; Diabetes Society; European Society for Paediatric Endocrinology; British Diabetic Association (BDA); The European Association for the study of Diabetes; Society for Biomedical Diabetes Research; French Language Association for the Diabetes Study ALFEDIAM 


Track 12 : Challenges inEndocrinology & Diabetes

Major new health issues confront us some of which arise from our modern lifestyle and its consequent energy imbalance. In addition to obesity and diabetes, metabolic disorders will soon overtake smoking as the main avoidable cause of cancer. Vitamin D is essential for bone, muscle and other aspects in health. Sunlight (UVB) is the most important source of vitamin D (>90%). The main natural food source is fish, Breast milk contains vitamin D. Skin colour: Adults with dark skin (Fitzpatrick types V and VI) require 3-6 times the amount of UVB compared to people with light skin.

Related Conference Diabetes | Diabetes Conferences | Diabetes Congress | Diabetes Meetings | Diabetologist | Endocrinology Conferences |

20th World Summit on Diabetes, Nutrition, Metabolism & Medicare July 24-26,2017 Vancouver, Canada; 23rd International Conference on Herbal and Alternative Remedies for Diabetes and Endocrine Disorders November 2-4, 2017 Bangkok, Thailand; 18th European Diabetes Congress July 17-18, 2017 Lisbon, Portugal; 10th Diabetologists Conference July 24-26,2017 Vancouver, Canada; 19th Asia Pacific Diabetes Conference July 20-22, 2017 Melbourne, Australia; 16th Global Diabetes Conference & Medicare Expo March 22-23, 2017 Rome, Italy; 8th International Conference on Adrenal & Thyroid Disorders, Treatment June 12-13, 2017 Taiwan, Taipei; 13th World Congress on Diabetes  October 05-06, 2017 London, UK; 12th International Conference on Endocrinology and Diabetes Summit November 06-07, 2017 Singapore.

Related Diabetes Societies and Associations

The Scandinavian society for the study of diabetes; American Diabetes Association; European Association for the Study of Diabetes -DNSG-EASD; World Glaucoma Association; Austrian Society for Urology (OGU); Cyprus Endocrine Society; Endocrine Pathology Society; Diabetes Technology Society; International Society of Endocrinology; International Association of Endocrine Surgeons; Canadian Diabetes Association; ALAD Latin American Diabetes Association

Market Analysis

“26th International Conference on Clinical Diabetes” is going to be held during December 14-15, 2017 at Rome, Italy. Clinical Diabetes 2017 conference gathers renowned scientists, physicians, surgeons, young researchers, industrial delegates and talented student communities in the field of diabetic medicine under a single roof where networking and global partnering happens for the acceleration of future research.

The conference throws light on thought provoking topics and recent research in the field of Diabetic Medications like, Type 1 Diabetes- Therapies and treatments, Type 2 Diabetes- Therapies and treatments, Diabetic Neuropathy-Treatment and Care, Management of Diabetic Heart Diseases, Management of Diabetic Kidney Diseases, Clinical Diabetic Therapeutics & Management, Islet Biology and Beta cell targeting, Computational Approaches for Diabetes, and many more. The organizing committee is gearing up for an exciting and informative conference program including plenary lectures, symposia, workshops on a variety of topics, poster presentations and various programs for participants from all over the world. We invite you to join us at the Diabetes International Conference, where you are sure to have a meaningful experience with scholars from around the world. All the Organizing Committee Members of the Clinical Diabetes 2017 International Conference look forward to meet you in Rome, Italy

For more details please visit- http://diabetes.alliedacademies.com/

Allied Academic Publication is an amalgamation of several esteemed academic and scientific associations known for promoting scientific temperament. Established in the year 1997, Andrew John Publishing Group is a specialized Medical publisher that operates in collaboration with the association and societies.  This publishing house has been built on the base of esteemed academic and research institutions including The College of Audiologists and Speech Language Pathologists of Ontario(CASLPO), The Association for Public Safety Communications Officials of Canada (APCO), The Canadian Vascular Access Association (CVAA), The Canadian Society of Internal Medicine (CSIM), The Canadian Hard of Hearing Association (CHHA), Sonography Canada, Canadian Association of Pathologists (CAP-ACP) and The Canadian Association of Neurophysiologic Monitoring (CANM).

Importance & Scope:

The prevalence of diabetes for all age-groups worldwide was estimated to be 2.8% in 2000 and 4.4% in 2030. The total number of people with diabetes is projected to rise from 171 million in 2000 to 366 million in 2030. The prevalence of diabetes is higher in men than women, but there are more women with diabetes than men. The urban population in developing countries is projected to double between 2000 and 2030. The most important demographic change to diabetes prevalence across the world appears to be the increase in the proportion of people >65 years of age. These findings indicate that the “diabetes epidemic” will continue even if levels of obesity remain constant. Given the increasing prevalence of obesity, it is likely that these figures provide an underestimate of future diabetes prevalence.

The number of people with diabetes has risen from 108 million in 1980 to 422 million in 2014. The global prevalence of diabetes* among adults over 18 years of age has risen from 4.7% in 1980 to 8.5% in 2014. In 2012, an estimated 1.5 million deaths were directly caused by diabetes and another 2.2 million deaths were attributable to high blood glucose. Almost half of all deaths attributable to high blood glucose occur before the age of 70 years1. WHO projects that diabetes will be the 7th leading cause of death in 2030.

Clinical Diabetes 2017 will feature the latest developments in research, diagnosis and prevention and management of diabetes, new insulin analogues and new technologies and devices for diabetic prevention, and for treating obesity and many more. Not only will this innovative conference enhance your practical and theoretical knowledge, it will provide you with the unique opportunity to network with a wide range of professionals in the field of diabetes technologies and treatments.

Why Italy?

The prevalence of diabetes as well as glucose intolerance is greater in men and in the regions of the Centre and South of Italy. The prevalence of diabetes has doubled in Italy over the past decade and now affects about 3 million people. In Italy, the prevalence of diabetes is 6.6% among people over 20 years old, The Italian Ministry of Health estimates that the number of total undiagnosed cases of diabetes is approximately 2 million. By 2013, the number of cases of both type 1 and type 2 are expected to rise to about 2.7 million and 4 million, respectively. Current diabetes incidence ranges from 4 to 10 new cases per 100,000 inhabitants annually throughout most of the country, but is as high as 35 new cases per 100,000 in Sardinia. Approximately 15,000 new cases of type 1 diabetes and 185,000 new cases of type 2 diabetes are diagnosed nationwide each year, resulting in a and a type 1:type 2 ratio of 1:9. One recent study by the Association Medical Dialectology (AMD, the Italian Association of Diabetes Doctors) found that the number of cases of both type 1 and type 2 diabetes is increasing at about 1% and 7-10% per year, likely due in part to improved screening measures and an increase in obesity and sedentary lifestyles. Reflecting this imperative Clinical Diabetes -2017 aims to educate paediatricians and achieve the goal of reducing infant mortality rate.

Societies Associated with Diabetes Research

Association National Italian Diabetic Athletes

International Diabetes Federation- Italy

Primary Care Diabetes Society

FAND - Italian Association of Diabetics

Italian Association for the Defence of the Interests of Diabetics

Association of Diabetes

Italian Society of Diabetology

Australian Diabetes Society

Emirates Diabetes Society

Society for Biomedica lDiabetes Research

Diabetes Association of Nigeria

Association of Children's Diabetes Clinicians

Today’s Market Study of Diabetes in USA | Europe | Middle East | Asia Pacific

Europe: The number of people living with diabetes in Europe is expected to increase from 52 million in 2014 to 68.9 million by 2035, according to the International Diabetes Federation (IDF). Across Europe, around 1 in 11 adults is affected and this number is set to rise as the population ages.

USA: Diabetes Mellitus has been growing at an exponential rate and World Health Organization (WHO) estimates that the diabetic population is likely to reach 366 million in 2030. The United States is expected to have an increase of 102 per cent in the diabetic epidemic in 2030 when compared to 2000.

Middle East: The rate of diabetes in parts of the Arabian Peninsula is over twice the global average rate, and much higher than some other areas of the Middle East and North Africa (MENA). And cases of type-2 diabetes outnumber cases of type-1 diabetes by a ratio of 10:1.

Asia Pacific: The Asia-Pacific Diabetes Care Devices Market has been estimated at USD 2.461 Billion in 2015 and is projected to reach USD 3.518 billion by 2020, at a CAGR of 7.41% during the forecast period from 2015 to 2020.

Market Value on Diabetic Research:

The impact of diabetes on the individual quality of life and general economy in Italy is substantial. Healthcare costs for patients with diabetes in Italy are estimated at approximately €5.5 billion annually, representing more than 6% of total national healthcare spending. The Cost of Diabetes in Europe—Type 2 Study(CODE-2), which measured the total healthcare costs for patients with type 2 diabetes in 8 European countries (Italy, Belgium, France, Germany, Netherlands, Spain, Sweden, and UK), found the total yearly (1998) costs for people with type 2 diabetes in Italy alone to be almost €5.2 billion, a per-patient expenditure of at least €2900. Among patients with type 2 diabetes in Italy examined by the CODE-2 study, 17.8% were hospitalized during the 6 month study, with an average hospital stay of 13 days. The cost of hospitalizations accounted for the greatest portion of total costs for all countries in the study, at 55%, leading non-anti diabetic drugs (21%), outpatient care (18%) and anti-diabetic drugs (7%).[3] Among non-anti diabetic drugs, the majority were cardiovascular and lipid-lowering (42%).[3] Annual per-patient costs vary widely with primary treatment type, with the highest per-patient costs accrued by those treated with diet and exercise alone.

Organizing Committee
OCM Member
Schwartz Stanley
Perelman School of Medicine
Philadelphia, USA
OCM Member
Khalid Matrougui
Eastern Virginia Medical School
Virginia, USA
OCM Member
RAZ ITAMAR
Hadassah Medical School
Haifa, Israel
OCM Member
Manuela Rodriquez
University of Salerno
Salerno, Italy
OCM Member
Giuseppe Mancia
University of Milano-Bicocca
Genoa, Italy
OCM Member
Giuseppe Ambrosio
University of Perugia
Genoa, Italy
OCM Member
Guido Grassi
University of Milano-Bicocca
Genoa, Italy
OCM Member
Yousef Shahin
UNRWA
Amman, Jordan

To Collaborate Scientific Professionals around the World

Conference Date December 14-15, 2017
Speaker Oppurtunity
Poster Oppurtunity Available
e-Poster Oppurtunity Available
Sponsorship Opportunities Click here for Sponsorship Opportunities
Venue
&
Hospitality

Holiday Inn Rome Aurelia
Via Aurelia Km 8,400
00163 Rome, Italy

Conference Dates: December 14-16, 2017

Join The Discussion

Mail us at

Drop us an email for Program enquiry.
diabetes@alliedconferences.org
Sponsors/Exhibiting/Advertising
diabetes@alliedconference.com
General Queries
diabetes@alliedconferences.org
Copyright © 2017-2018 Allied Academies, All Rights Reserved.